Corbenic Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-101
| Closed | -$7K | – | 277 |
|
|
2021
Q2 | $7K | Buy |
101
+20
| +25% | +$1.39K | ﹤0.01% | 194 |
|
|
2021
Q1 | $5K | Buy |
+81
| New | +$5K | ﹤0.01% | 201 |
|
|
2020
Q2 | – | Sell |
-50
| Closed | -$3K | – | 163 |
|
|
2020
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 136 |
|
|
2019
Q4 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 146 |
|
|
2017
Q4 | $49K | Hold |
800
| – | – | 0.06% | 63 |
|
|
2017
Q3 | $51K | Hold |
800
| – | – | 0.07% | 66 |
|
|
2017
Q2 | $45K | Hold |
800
| – | – | 0.06% | 68 |
|
|
2017
Q1 | $44K | Sell |
800
-306
| -28% | -$16.8K | 0.05% | 73 |
|
|
2016
Q4 | $65K | Hold |
1,106
| – | – | 0.07% | 60 |
|
|
2016
Q3 | $60K | Buy |
1,106
+306
| +38% | +$16.6K | 0.06% | 65 |
|
|
2016
Q2 | $59K | Hold |
800
| – | – | 0.06% | 61 |
|
|
2016
Q1 | $51K | Sell |
800
-104
| -12% | -$6.63K | 0.05% | 62 |
|
|
2015
Q4 | $62K | Buy |
904
+104
| +13% | +$7.13K | 0.06% | 51 |
|
|
2015
Q3 | $47K | Buy |
+800
| New | +$47K | 0.04% | 60 |
|